A study soon to published found that palliative care for patients with ovarian cancer was often provided later than recommended in national guidelines.
A recent study evaluated the impact of a geriatric oncology clinic on cancer treatment plans and supportive care in older adults with genitourinary cancers.
The National Comprehensive Cancer Network updated their induction and consolidation treatment recommendations for low-risk and high-risk acute myeloid leukemia.
The FDA has approved a hormone-based chemotherapy in combination with prednisone for metastatic high-risk castration-sensitive prostate cancer.
A cost-effectiveness analysis presented at the 2018 Genitourinary Cancers Symposium examined the use of a hydrogel rectal spacer in patients with prostate cancer undergoing intensity-modulated radiation therapy.
Human epidermal growth factor receptor 2 may be a potential marker of poor prognosis in patients with unclassified ovarian cancer, according to a recent meta-analysis.
The American Society of Clinical Oncology as endorsed other professional societies’ molecular guidelines on selecting patients with lung cancer for treatment with targeted tyrosine kinase inhibitors.
Shape Change at Every Step
About 15% of Medicare recipients and 23% of those with commercial insurance undergo breast biopsy by 10-year follow-up, and biopsy is associated significantly with age, initial treatment type and subsequent chemotherapy.
Researchers compared the overall survival, cancer-specific survival, and associated costs of trimodal therapy versus radical cystectomy for patients with localized muscle-invasive bladder cancer.